Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Guignabert

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Breathe (Sheffield, England)|January 23, 2025
From basic scientific research to the development of new drugs for pulmonary arterial hypertension: insights from activin-targeting agentsChristophe Guignabert
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 3, 2019
Multiple roles of macrophage migration inhibitory factor in pulmonary hypertensionGael Jalce, Christophe Guignabert
The European Respiratory Journal|August 21, 2020
Targeting transforming growth factor-β receptors in pulmonary hypertensionChristophe Guignabert, Marc Humbert
Seminars in Respiratory and Critical Care Medicine|September 17, 2013
Pathology and pathobiology of pulmonary hypertensionChristophe Guignabert, Peter Dorfmuller
Handbook of Experimental Pharmacology|October 5, 2013
Emerging molecular targets for anti-proliferative strategies in pulmonary arterial hypertensionLy Tu, Christophe Guignabert
Expert Opinion on Therapeutic Targets|December 22, 2016
Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitationsChristophe Guignabert, Sabine Bailly, Marc Humbert
Current Opinion in Pulmonary Medicine|June 6, 2017
New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathwaysAlice Huertas, Ly Tu, Christophe Guignabert
Nature Reviews. Cardiology|February 25, 2021
The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcyNicolas Ricard, Sabine Bailly, Christophe Guignabert, et al.
Circulation Research|April 28, 2022
New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease PathogenesisMicheala A Aldred, Nicholas W Morrell, Christophe Guignabert
European Respiratory Review : an Official Journal of the European Respiratory Society|April 15, 2018
Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new eraLaurent Savale, Christophe Guignabert, Jason Weatherald, et al.
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Breathe (Sheffield, England)|January 23, 2025
From basic scientific research to the development of new drugs for pulmonary arterial hypertension: insights from activin-targeting agentsChristophe Guignabert
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 3, 2019
Multiple roles of macrophage migration inhibitory factor in pulmonary hypertensionGael Jalce, Christophe Guignabert
The European Respiratory Journal|August 21, 2020
Targeting transforming growth factor-β receptors in pulmonary hypertensionChristophe Guignabert, Marc Humbert
Seminars in Respiratory and Critical Care Medicine|September 17, 2013
Pathology and pathobiology of pulmonary hypertensionChristophe Guignabert, Peter Dorfmuller
Handbook of Experimental Pharmacology|October 5, 2013
Emerging molecular targets for anti-proliferative strategies in pulmonary arterial hypertensionLy Tu, Christophe Guignabert
Expert Opinion on Therapeutic Targets|December 22, 2016
Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitationsChristophe Guignabert, Sabine Bailly, Marc Humbert
Current Opinion in Pulmonary Medicine|June 6, 2017
New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathwaysAlice Huertas, Ly Tu, Christophe Guignabert
Nature Reviews. Cardiology|February 25, 2021
The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcyNicolas Ricard, Sabine Bailly, Christophe Guignabert, et al.
Circulation Research|April 28, 2022
New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease PathogenesisMicheala A Aldred, Nicholas W Morrell, Christophe Guignabert
European Respiratory Review : an Official Journal of the European Respiratory Society|April 15, 2018
Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new eraLaurent Savale, Christophe Guignabert, Jason Weatherald, et al.
Pageof 16